期刊
CURRENT OPINION IN VIROLOGY
卷 8, 期 -, 页码 45-53出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2014.06.002
关键词
-
类别
资金
- National Institutes of Health [AI076119, AI099284, AI100890, AI112417, GM103368]
- Ministry of Knowledge and Economy, Bilateral International Collaborative R&D Program, Republic of Korea
Coronaviruses are positive stranded RNA viruses that cause respiratory, enteric and central nervous system diseases in many species, including humans. Until recently, the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics. However, the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV), and more recently, Middle East respiratory syndrome coronavirus (MERS-CoV), has impelled the development of such drugs. This review focuses on some newly identified SARS-CoV inhibitors, with known mechanisms of action and their potential to inhibit the novel MERS-CoV. The clinical development of optimized versions of such compounds could be beneficial for the treatment and control of SARS-CoV, the current MERS-CoV and other future SARS-like epidemics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据